- £77.87m
- £145.76m
- £149.33m
- 68
- 82
- 72
- 90
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 78.5 | 86.8 | 118 | 138 | 149 |
Cost of Revenue | |||||
Gross Profit | 62.8 | 68 | 91.5 | 106 | 118 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 53.9 | 68.7 | 90.9 | 108 | 110 |
Operating Profit | 24.6 | 18.1 | 27.4 | 30.4 | 39.8 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 22.4 | 15.5 | 23.7 | 24.1 | 23 |
Provision for Income Taxes | |||||
Net Income After Taxes | 18 | 12.3 | 19.1 | 19.5 | 15.1 |
Net Income Before Extraordinary Items | |||||
Net Income | 18 | 12.3 | 19.1 | 19.5 | 15.1 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Dilution Adjustment | |||||
Diluted Net Income | 18 | 12.3 | 19.1 | 19.5 | 15.1 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.16 | 0.105 | 0.161 | 0.164 | 0.132 |
Dividends per Share |